Grant Skrepnek to Adjuvants, Immunologic
This is a "connection" page, showing publications Grant Skrepnek has written about Adjuvants, Immunologic.
Connection Strength
0.128
-
Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies. J Manag Care Pharm. 2013 Jan-Feb; 19(1 Suppl A):S41-53.
Score: 0.102
-
Intramuscular interferon beta-1a and evolving treatment options and outcomes measurement for MS: considerations for managed care. J Manag Care Pharm. 2013 Jan-Feb; 19(1 Suppl A):S1-53.
Score: 0.026